Medical Devices & Consumables
Global AI Medical Imaging Software for Lung Diseases Market Outlook, In‑Depth Analysis & Forecast to 2031
- Oct 21, 25
- ID: 558238
- Pages: 144
- Figures: 138
- Views: 13
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global AI Medical Imaging Software for Lung Diseases market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Siemens
Riverain Technologies
Deepwise
Shukun Technology
Infervision Medical
United-Imaging
Yizhun Intelligent
VoxelCloud
Fosun Aitrox
Huiying Medical
BioMind
Segment by Type
Pulmonary Nodules
Pneumonia
Other
Segment by Application
Hospital
Clinic
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the AI Medical Imaging Software for Lung Diseases study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global AI Medical Imaging Software for Lung Diseases market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Siemens
Riverain Technologies
Deepwise
Shukun Technology
Infervision Medical
United-Imaging
Yizhun Intelligent
VoxelCloud
Fosun Aitrox
Huiying Medical
BioMind
Segment by Type
Pulmonary Nodules
Pneumonia
Other
Segment by Application
Hospital
Clinic
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the AI Medical Imaging Software for Lung Diseases study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to AI Medical Imaging Software for Lung Diseases: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Pulmonary Nodules
1.2.3 Pneumonia
1.2.4 Other
1.3 Market Segmentation by Application
1.3.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global AI Medical Imaging Software for Lung Diseases Revenue Estimates and Forecasts 2020-2031
2.2 Global AI Medical Imaging Software for Lung Diseases Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global AI Medical Imaging Software for Lung Diseases Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global AI Medical Imaging Software for Lung Diseases Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Pulmonary Nodules Market Size by Players
3.3.2 Pneumonia Market Size by Players
3.3.3 Other Market Size by Players
3.4 Global AI Medical Imaging Software for Lung Diseases Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global AI Medical Imaging Software for Lung Diseases Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global AI Medical Imaging Software for Lung Diseases Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America AI Medical Imaging Software for Lung Diseases Market Size by Type (2020-2031)
6.4 North America AI Medical Imaging Software for Lung Diseases Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America AI Medical Imaging Software for Lung Diseases Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe AI Medical Imaging Software for Lung Diseases Market Size by Type (2020-2031)
7.4 Europe AI Medical Imaging Software for Lung Diseases Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe AI Medical Imaging Software for Lung Diseases Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Type (2020-2031)
8.4 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America AI Medical Imaging Software for Lung Diseases Market Size by Type (2020-2031)
9.4 Central and South America AI Medical Imaging Software for Lung Diseases Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America AI Medical Imaging Software for Lung Diseases Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa AI Medical Imaging Software for Lung Diseases Market Size by Type (2020-2031)
10.4 Middle East and Africa AI Medical Imaging Software for Lung Diseases Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa AI Medical Imaging Software for Lung Diseases Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Siemens
11.1.1 Siemens Corporation Information
11.1.2 Siemens Business Overview
11.1.3 Siemens AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.1.4 Siemens AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.1.5 Siemens AI Medical Imaging Software for Lung Diseases Revenue by Product in 2024
11.1.6 Siemens AI Medical Imaging Software for Lung Diseases Revenue by Application in 2024
11.1.7 Siemens AI Medical Imaging Software for Lung Diseases Revenue by Geographic Area in 2024
11.1.8 Siemens AI Medical Imaging Software for Lung Diseases SWOT Analysis
11.1.9 Siemens Recent Developments
11.2 Riverain Technologies
11.2.1 Riverain Technologies Corporation Information
11.2.2 Riverain Technologies Business Overview
11.2.3 Riverain Technologies AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.2.4 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.2.5 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue by Product in 2024
11.2.6 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue by Application in 2024
11.2.7 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue by Geographic Area in 2024
11.2.8 Riverain Technologies AI Medical Imaging Software for Lung Diseases SWOT Analysis
11.2.9 Riverain Technologies Recent Developments
11.3 Deepwise
11.3.1 Deepwise Corporation Information
11.3.2 Deepwise Business Overview
11.3.3 Deepwise AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.3.4 Deepwise AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.3.5 Deepwise AI Medical Imaging Software for Lung Diseases Revenue by Product in 2024
11.3.6 Deepwise AI Medical Imaging Software for Lung Diseases Revenue by Application in 2024
11.3.7 Deepwise AI Medical Imaging Software for Lung Diseases Revenue by Geographic Area in 2024
11.3.8 Deepwise AI Medical Imaging Software for Lung Diseases SWOT Analysis
11.3.9 Deepwise Recent Developments
11.4 Shukun Technology
11.4.1 Shukun Technology Corporation Information
11.4.2 Shukun Technology Business Overview
11.4.3 Shukun Technology AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.4.4 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.4.5 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue by Product in 2024
11.4.6 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue by Application in 2024
11.4.7 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue by Geographic Area in 2024
11.4.8 Shukun Technology AI Medical Imaging Software for Lung Diseases SWOT Analysis
11.4.9 Shukun Technology Recent Developments
11.5 Infervision Medical
11.5.1 Infervision Medical Corporation Information
11.5.2 Infervision Medical Business Overview
11.5.3 Infervision Medical AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.5.4 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.5.5 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue by Product in 2024
11.5.6 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue by Application in 2024
11.5.7 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue by Geographic Area in 2024
11.5.8 Infervision Medical AI Medical Imaging Software for Lung Diseases SWOT Analysis
11.5.9 Infervision Medical Recent Developments
11.6 United-Imaging
11.6.1 United-Imaging Corporation Information
11.6.2 United-Imaging Business Overview
11.6.3 United-Imaging AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.6.4 United-Imaging AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.6.5 United-Imaging Recent Developments
11.7 Yizhun Intelligent
11.7.1 Yizhun Intelligent Corporation Information
11.7.2 Yizhun Intelligent Business Overview
11.7.3 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.7.4 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.7.5 Yizhun Intelligent Recent Developments
11.8 VoxelCloud
11.8.1 VoxelCloud Corporation Information
11.8.2 VoxelCloud Business Overview
11.8.3 VoxelCloud AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.8.4 VoxelCloud AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.8.5 VoxelCloud Recent Developments
11.9 Fosun Aitrox
11.9.1 Fosun Aitrox Corporation Information
11.9.2 Fosun Aitrox Business Overview
11.9.3 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.9.4 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.9.5 Fosun Aitrox Recent Developments
11.10 Huiying Medical
11.10.1 Huiying Medical Corporation Information
11.10.2 Huiying Medical Business Overview
11.10.3 Huiying Medical AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.10.4 Huiying Medical AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 BioMind
11.11.1 BioMind Corporation Information
11.11.2 BioMind Business Overview
11.11.3 BioMind AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.11.4 BioMind AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.11.5 BioMind Recent Developments
12 AI Medical Imaging Software for Lung DiseasesIndustry Chain Analysis
12.1 AI Medical Imaging Software for Lung Diseases Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 AI Medical Imaging Software for Lung Diseases Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global AI Medical Imaging Software for Lung Diseases Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to AI Medical Imaging Software for Lung Diseases: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Pulmonary Nodules
1.2.3 Pneumonia
1.2.4 Other
1.3 Market Segmentation by Application
1.3.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global AI Medical Imaging Software for Lung Diseases Revenue Estimates and Forecasts 2020-2031
2.2 Global AI Medical Imaging Software for Lung Diseases Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global AI Medical Imaging Software for Lung Diseases Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global AI Medical Imaging Software for Lung Diseases Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Pulmonary Nodules Market Size by Players
3.3.2 Pneumonia Market Size by Players
3.3.3 Other Market Size by Players
3.4 Global AI Medical Imaging Software for Lung Diseases Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global AI Medical Imaging Software for Lung Diseases Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global AI Medical Imaging Software for Lung Diseases Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America AI Medical Imaging Software for Lung Diseases Market Size by Type (2020-2031)
6.4 North America AI Medical Imaging Software for Lung Diseases Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America AI Medical Imaging Software for Lung Diseases Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe AI Medical Imaging Software for Lung Diseases Market Size by Type (2020-2031)
7.4 Europe AI Medical Imaging Software for Lung Diseases Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe AI Medical Imaging Software for Lung Diseases Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Type (2020-2031)
8.4 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America AI Medical Imaging Software for Lung Diseases Market Size by Type (2020-2031)
9.4 Central and South America AI Medical Imaging Software for Lung Diseases Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America AI Medical Imaging Software for Lung Diseases Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa AI Medical Imaging Software for Lung Diseases Market Size by Type (2020-2031)
10.4 Middle East and Africa AI Medical Imaging Software for Lung Diseases Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa AI Medical Imaging Software for Lung Diseases Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Siemens
11.1.1 Siemens Corporation Information
11.1.2 Siemens Business Overview
11.1.3 Siemens AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.1.4 Siemens AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.1.5 Siemens AI Medical Imaging Software for Lung Diseases Revenue by Product in 2024
11.1.6 Siemens AI Medical Imaging Software for Lung Diseases Revenue by Application in 2024
11.1.7 Siemens AI Medical Imaging Software for Lung Diseases Revenue by Geographic Area in 2024
11.1.8 Siemens AI Medical Imaging Software for Lung Diseases SWOT Analysis
11.1.9 Siemens Recent Developments
11.2 Riverain Technologies
11.2.1 Riverain Technologies Corporation Information
11.2.2 Riverain Technologies Business Overview
11.2.3 Riverain Technologies AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.2.4 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.2.5 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue by Product in 2024
11.2.6 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue by Application in 2024
11.2.7 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue by Geographic Area in 2024
11.2.8 Riverain Technologies AI Medical Imaging Software for Lung Diseases SWOT Analysis
11.2.9 Riverain Technologies Recent Developments
11.3 Deepwise
11.3.1 Deepwise Corporation Information
11.3.2 Deepwise Business Overview
11.3.3 Deepwise AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.3.4 Deepwise AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.3.5 Deepwise AI Medical Imaging Software for Lung Diseases Revenue by Product in 2024
11.3.6 Deepwise AI Medical Imaging Software for Lung Diseases Revenue by Application in 2024
11.3.7 Deepwise AI Medical Imaging Software for Lung Diseases Revenue by Geographic Area in 2024
11.3.8 Deepwise AI Medical Imaging Software for Lung Diseases SWOT Analysis
11.3.9 Deepwise Recent Developments
11.4 Shukun Technology
11.4.1 Shukun Technology Corporation Information
11.4.2 Shukun Technology Business Overview
11.4.3 Shukun Technology AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.4.4 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.4.5 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue by Product in 2024
11.4.6 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue by Application in 2024
11.4.7 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue by Geographic Area in 2024
11.4.8 Shukun Technology AI Medical Imaging Software for Lung Diseases SWOT Analysis
11.4.9 Shukun Technology Recent Developments
11.5 Infervision Medical
11.5.1 Infervision Medical Corporation Information
11.5.2 Infervision Medical Business Overview
11.5.3 Infervision Medical AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.5.4 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.5.5 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue by Product in 2024
11.5.6 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue by Application in 2024
11.5.7 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue by Geographic Area in 2024
11.5.8 Infervision Medical AI Medical Imaging Software for Lung Diseases SWOT Analysis
11.5.9 Infervision Medical Recent Developments
11.6 United-Imaging
11.6.1 United-Imaging Corporation Information
11.6.2 United-Imaging Business Overview
11.6.3 United-Imaging AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.6.4 United-Imaging AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.6.5 United-Imaging Recent Developments
11.7 Yizhun Intelligent
11.7.1 Yizhun Intelligent Corporation Information
11.7.2 Yizhun Intelligent Business Overview
11.7.3 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.7.4 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.7.5 Yizhun Intelligent Recent Developments
11.8 VoxelCloud
11.8.1 VoxelCloud Corporation Information
11.8.2 VoxelCloud Business Overview
11.8.3 VoxelCloud AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.8.4 VoxelCloud AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.8.5 VoxelCloud Recent Developments
11.9 Fosun Aitrox
11.9.1 Fosun Aitrox Corporation Information
11.9.2 Fosun Aitrox Business Overview
11.9.3 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.9.4 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.9.5 Fosun Aitrox Recent Developments
11.10 Huiying Medical
11.10.1 Huiying Medical Corporation Information
11.10.2 Huiying Medical Business Overview
11.10.3 Huiying Medical AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.10.4 Huiying Medical AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 BioMind
11.11.1 BioMind Corporation Information
11.11.2 BioMind Business Overview
11.11.3 BioMind AI Medical Imaging Software for Lung Diseases Product Features and Attributes
11.11.4 BioMind AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)
11.11.5 BioMind Recent Developments
12 AI Medical Imaging Software for Lung DiseasesIndustry Chain Analysis
12.1 AI Medical Imaging Software for Lung Diseases Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 AI Medical Imaging Software for Lung Diseases Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global AI Medical Imaging Software for Lung Diseases Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global AI Medical Imaging Software for Lung Diseases Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global AI Medical Imaging Software for Lung Diseases Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global AI Medical Imaging Software for Lung Diseases Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global AI Medical Imaging Software for Lung Diseases by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Medical Imaging Software for Lung Diseases as of 2024)
Table 11. Global AI Medical Imaging Software for Lung Diseases Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global AI Medical Imaging Software for Lung Diseases Companies Headquarters
Table 13. Global AI Medical Imaging Software for Lung Diseases Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global AI Medical Imaging Software for Lung Diseases Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global AI Medical Imaging Software for Lung Diseases Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global AI Medical Imaging Software for Lung Diseases Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global AI Medical Imaging Software for Lung Diseases Revenue by Application (2026-2031) & (US$ Million)
Table 21. AI Medical Imaging Software for Lung Diseases High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America AI Medical Imaging Software for Lung Diseases Growth Accelerators and Market Barriers
Table 25. North America AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe AI Medical Imaging Software for Lung Diseases Growth Accelerators and Market Barriers
Table 27. Europe AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific AI Medical Imaging Software for Lung Diseases Growth Accelerators and Market Barriers
Table 29. Asia-Pacific AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America AI Medical Imaging Software for Lung Diseases Investment Opportunities and Key Challenges
Table 31. Central and South America AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa AI Medical Imaging Software for Lung Diseases Investment Opportunities and Key Challenges
Table 33. Middle East and Africa AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Siemens Corporation Information
Table 35. Siemens Description and Major Businesses
Table 36. Siemens Product Features and Attributes
Table 37. Siemens Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Siemens Revenue Proportion by Product in 2024
Table 39. Siemens Revenue Proportion by Application in 2024
Table 40. Siemens Revenue Proportion by Geographic Area in 2024
Table 41. Siemens AI Medical Imaging Software for Lung Diseases SWOT Analysis
Table 42. Siemens Recent Developments
Table 43. Riverain Technologies Corporation Information
Table 44. Riverain Technologies Description and Major Businesses
Table 45. Riverain Technologies Product Features and Attributes
Table 46. Riverain Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Riverain Technologies Revenue Proportion by Product in 2024
Table 48. Riverain Technologies Revenue Proportion by Application in 2024
Table 49. Riverain Technologies Revenue Proportion by Geographic Area in 2024
Table 50. Riverain Technologies AI Medical Imaging Software for Lung Diseases SWOT Analysis
Table 51. Riverain Technologies Recent Developments
Table 52. Deepwise Corporation Information
Table 53. Deepwise Description and Major Businesses
Table 54. Deepwise Product Features and Attributes
Table 55. Deepwise Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Deepwise Revenue Proportion by Product in 2024
Table 57. Deepwise Revenue Proportion by Application in 2024
Table 58. Deepwise Revenue Proportion by Geographic Area in 2024
Table 59. Deepwise AI Medical Imaging Software for Lung Diseases SWOT Analysis
Table 60. Deepwise Recent Developments
Table 61. Shukun Technology Corporation Information
Table 62. Shukun Technology Description and Major Businesses
Table 63. Shukun Technology Product Features and Attributes
Table 64. Shukun Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Shukun Technology Revenue Proportion by Product in 2024
Table 66. Shukun Technology Revenue Proportion by Application in 2024
Table 67. Shukun Technology Revenue Proportion by Geographic Area in 2024
Table 68. Shukun Technology AI Medical Imaging Software for Lung Diseases SWOT Analysis
Table 69. Shukun Technology Recent Developments
Table 70. Infervision Medical Corporation Information
Table 71. Infervision Medical Description and Major Businesses
Table 72. Infervision Medical Product Features and Attributes
Table 73. Infervision Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Infervision Medical Revenue Proportion by Product in 2024
Table 75. Infervision Medical Revenue Proportion by Application in 2024
Table 76. Infervision Medical Revenue Proportion by Geographic Area in 2024
Table 77. Infervision Medical AI Medical Imaging Software for Lung Diseases SWOT Analysis
Table 78. Infervision Medical Recent Developments
Table 79. United-Imaging Corporation Information
Table 80. United-Imaging Description and Major Businesses
Table 81. United-Imaging Product Features and Attributes
Table 82. United-Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. United-Imaging Recent Developments
Table 84. Yizhun Intelligent Corporation Information
Table 85. Yizhun Intelligent Description and Major Businesses
Table 86. Yizhun Intelligent Product Features and Attributes
Table 87. Yizhun Intelligent Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Yizhun Intelligent Recent Developments
Table 89. VoxelCloud Corporation Information
Table 90. VoxelCloud Description and Major Businesses
Table 91. VoxelCloud Product Features and Attributes
Table 92. VoxelCloud Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. VoxelCloud Recent Developments
Table 94. Fosun Aitrox Corporation Information
Table 95. Fosun Aitrox Description and Major Businesses
Table 96. Fosun Aitrox Product Features and Attributes
Table 97. Fosun Aitrox Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Fosun Aitrox Recent Developments
Table 99. Huiying Medical Corporation Information
Table 100. Huiying Medical Description and Major Businesses
Table 101. Huiying Medical Product Features and Attributes
Table 102. Huiying Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Huiying Medical Recent Developments
Table 104. BioMind Corporation Information
Table 105. BioMind Description and Major Businesses
Table 106. BioMind Product Features and Attributes
Table 107. BioMind Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. BioMind Recent Developments
Table 109. Raw Materials Key Suppliers
Table 110. Distributors List
Table 111. Market Trends and Market Evolution
Table 112. Market Drivers and Opportunities
Table 113. Market Challenges, Risks, and Restraints
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. AI Medical Imaging Software for Lung Diseases Product Picture
Figure 2. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Pulmonary Nodules Product Picture
Figure 4. Pneumonia Product Picture
Figure 5. Other Product Picture
Figure 6. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospital
Figure 8. Clinic
Figure 9. AI Medical Imaging Software for Lung Diseases Report Years Considered
Figure 10. Global AI Medical Imaging Software for Lung Diseases Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 12. Global AI Medical Imaging Software for Lung Diseases Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Region (2020-2031)
Figure 14. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Pulmonary Nodules Revenue Market Share by Player in 2024
Figure 17. Pneumonia Revenue Market Share by Player in 2024
Figure 18. Other Revenue Market Share by Player in 2024
Figure 19. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Type (2020-2031)
Figure 20. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Application (2020-2031)
Figure 21. North America AI Medical Imaging Software for Lung Diseases Revenue YoY (2020-2031) & (US$ Million)
Figure 22. North America Top 5 Players AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) in 2024
Figure 23. North America AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Type (2020 - 2031)
Figure 24. North America AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Application (2020-2031)
Figure 25. US AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 26. Canada AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 27. Mexico AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 28. Europe AI Medical Imaging Software for Lung Diseases Revenue YoY (2020-2031) & (US$ Million)
Figure 29. Europe Top 5 Players AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) in 2024
Figure 30. Europe AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Type (2020-2031)
Figure 31. Europe AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Application (2020-2031)
Figure 32. Germany AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 33. France AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 34. U.K. AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 35. Italy AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 36. Russia AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific AI Medical Imaging Software for Lung Diseases Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Top 8 Players AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) in 2024
Figure 39. Asia-Pacific AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Type (2020-2031)
Figure 40. Asia-Pacific AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Application (2020-2031)
Figure 41. Indonesia AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 42. Japan AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 43. South Korea AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 44. Australia AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 45. India AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 46. Indonesia AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 47. Vietnam AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 48. Malaysia AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 49. Philippines AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 50. Singapore AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 51. Central and South America AI Medical Imaging Software for Lung Diseases Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Central and South America Top 5 Players AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) in 2024
Figure 53. Central and South America AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Type (2020-2031)
Figure 54. Central and South America AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Application (2020-2031)
Figure 55. Brazil AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)
Figure 56. Argentina AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)
Figure 57. Middle East and Africa AI Medical Imaging Software for Lung Diseases Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Top 5 Players AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) in 2024
Figure 59. South America AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Type (2020-2031)
Figure 60. Middle East and Africa AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Application (2020-2031)
Figure 61. GCC Countries AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)
Figure 62. Israel AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)
Figure 63. Egypt AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)
Figure 64. South Africa AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)
Figure 65. AI Medical Imaging Software for Lung Diseases Industry Chain Mapping
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global AI Medical Imaging Software for Lung Diseases Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global AI Medical Imaging Software for Lung Diseases Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global AI Medical Imaging Software for Lung Diseases Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global AI Medical Imaging Software for Lung Diseases by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Medical Imaging Software for Lung Diseases as of 2024)
Table 11. Global AI Medical Imaging Software for Lung Diseases Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global AI Medical Imaging Software for Lung Diseases Companies Headquarters
Table 13. Global AI Medical Imaging Software for Lung Diseases Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global AI Medical Imaging Software for Lung Diseases Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global AI Medical Imaging Software for Lung Diseases Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global AI Medical Imaging Software for Lung Diseases Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global AI Medical Imaging Software for Lung Diseases Revenue by Application (2026-2031) & (US$ Million)
Table 21. AI Medical Imaging Software for Lung Diseases High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America AI Medical Imaging Software for Lung Diseases Growth Accelerators and Market Barriers
Table 25. North America AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe AI Medical Imaging Software for Lung Diseases Growth Accelerators and Market Barriers
Table 27. Europe AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific AI Medical Imaging Software for Lung Diseases Growth Accelerators and Market Barriers
Table 29. Asia-Pacific AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America AI Medical Imaging Software for Lung Diseases Investment Opportunities and Key Challenges
Table 31. Central and South America AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa AI Medical Imaging Software for Lung Diseases Investment Opportunities and Key Challenges
Table 33. Middle East and Africa AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Siemens Corporation Information
Table 35. Siemens Description and Major Businesses
Table 36. Siemens Product Features and Attributes
Table 37. Siemens Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Siemens Revenue Proportion by Product in 2024
Table 39. Siemens Revenue Proportion by Application in 2024
Table 40. Siemens Revenue Proportion by Geographic Area in 2024
Table 41. Siemens AI Medical Imaging Software for Lung Diseases SWOT Analysis
Table 42. Siemens Recent Developments
Table 43. Riverain Technologies Corporation Information
Table 44. Riverain Technologies Description and Major Businesses
Table 45. Riverain Technologies Product Features and Attributes
Table 46. Riverain Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Riverain Technologies Revenue Proportion by Product in 2024
Table 48. Riverain Technologies Revenue Proportion by Application in 2024
Table 49. Riverain Technologies Revenue Proportion by Geographic Area in 2024
Table 50. Riverain Technologies AI Medical Imaging Software for Lung Diseases SWOT Analysis
Table 51. Riverain Technologies Recent Developments
Table 52. Deepwise Corporation Information
Table 53. Deepwise Description and Major Businesses
Table 54. Deepwise Product Features and Attributes
Table 55. Deepwise Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Deepwise Revenue Proportion by Product in 2024
Table 57. Deepwise Revenue Proportion by Application in 2024
Table 58. Deepwise Revenue Proportion by Geographic Area in 2024
Table 59. Deepwise AI Medical Imaging Software for Lung Diseases SWOT Analysis
Table 60. Deepwise Recent Developments
Table 61. Shukun Technology Corporation Information
Table 62. Shukun Technology Description and Major Businesses
Table 63. Shukun Technology Product Features and Attributes
Table 64. Shukun Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Shukun Technology Revenue Proportion by Product in 2024
Table 66. Shukun Technology Revenue Proportion by Application in 2024
Table 67. Shukun Technology Revenue Proportion by Geographic Area in 2024
Table 68. Shukun Technology AI Medical Imaging Software for Lung Diseases SWOT Analysis
Table 69. Shukun Technology Recent Developments
Table 70. Infervision Medical Corporation Information
Table 71. Infervision Medical Description and Major Businesses
Table 72. Infervision Medical Product Features and Attributes
Table 73. Infervision Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Infervision Medical Revenue Proportion by Product in 2024
Table 75. Infervision Medical Revenue Proportion by Application in 2024
Table 76. Infervision Medical Revenue Proportion by Geographic Area in 2024
Table 77. Infervision Medical AI Medical Imaging Software for Lung Diseases SWOT Analysis
Table 78. Infervision Medical Recent Developments
Table 79. United-Imaging Corporation Information
Table 80. United-Imaging Description and Major Businesses
Table 81. United-Imaging Product Features and Attributes
Table 82. United-Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. United-Imaging Recent Developments
Table 84. Yizhun Intelligent Corporation Information
Table 85. Yizhun Intelligent Description and Major Businesses
Table 86. Yizhun Intelligent Product Features and Attributes
Table 87. Yizhun Intelligent Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Yizhun Intelligent Recent Developments
Table 89. VoxelCloud Corporation Information
Table 90. VoxelCloud Description and Major Businesses
Table 91. VoxelCloud Product Features and Attributes
Table 92. VoxelCloud Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. VoxelCloud Recent Developments
Table 94. Fosun Aitrox Corporation Information
Table 95. Fosun Aitrox Description and Major Businesses
Table 96. Fosun Aitrox Product Features and Attributes
Table 97. Fosun Aitrox Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Fosun Aitrox Recent Developments
Table 99. Huiying Medical Corporation Information
Table 100. Huiying Medical Description and Major Businesses
Table 101. Huiying Medical Product Features and Attributes
Table 102. Huiying Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Huiying Medical Recent Developments
Table 104. BioMind Corporation Information
Table 105. BioMind Description and Major Businesses
Table 106. BioMind Product Features and Attributes
Table 107. BioMind Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. BioMind Recent Developments
Table 109. Raw Materials Key Suppliers
Table 110. Distributors List
Table 111. Market Trends and Market Evolution
Table 112. Market Drivers and Opportunities
Table 113. Market Challenges, Risks, and Restraints
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. AI Medical Imaging Software for Lung Diseases Product Picture
Figure 2. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Pulmonary Nodules Product Picture
Figure 4. Pneumonia Product Picture
Figure 5. Other Product Picture
Figure 6. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospital
Figure 8. Clinic
Figure 9. AI Medical Imaging Software for Lung Diseases Report Years Considered
Figure 10. Global AI Medical Imaging Software for Lung Diseases Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 12. Global AI Medical Imaging Software for Lung Diseases Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Region (2020-2031)
Figure 14. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Pulmonary Nodules Revenue Market Share by Player in 2024
Figure 17. Pneumonia Revenue Market Share by Player in 2024
Figure 18. Other Revenue Market Share by Player in 2024
Figure 19. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Type (2020-2031)
Figure 20. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Application (2020-2031)
Figure 21. North America AI Medical Imaging Software for Lung Diseases Revenue YoY (2020-2031) & (US$ Million)
Figure 22. North America Top 5 Players AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) in 2024
Figure 23. North America AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Type (2020 - 2031)
Figure 24. North America AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Application (2020-2031)
Figure 25. US AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 26. Canada AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 27. Mexico AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 28. Europe AI Medical Imaging Software for Lung Diseases Revenue YoY (2020-2031) & (US$ Million)
Figure 29. Europe Top 5 Players AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) in 2024
Figure 30. Europe AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Type (2020-2031)
Figure 31. Europe AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Application (2020-2031)
Figure 32. Germany AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 33. France AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 34. U.K. AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 35. Italy AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 36. Russia AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific AI Medical Imaging Software for Lung Diseases Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Top 8 Players AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) in 2024
Figure 39. Asia-Pacific AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Type (2020-2031)
Figure 40. Asia-Pacific AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Application (2020-2031)
Figure 41. Indonesia AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 42. Japan AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 43. South Korea AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 44. Australia AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 45. India AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 46. Indonesia AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 47. Vietnam AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 48. Malaysia AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 49. Philippines AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 50. Singapore AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)
Figure 51. Central and South America AI Medical Imaging Software for Lung Diseases Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Central and South America Top 5 Players AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) in 2024
Figure 53. Central and South America AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Type (2020-2031)
Figure 54. Central and South America AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Application (2020-2031)
Figure 55. Brazil AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)
Figure 56. Argentina AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)
Figure 57. Middle East and Africa AI Medical Imaging Software for Lung Diseases Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Top 5 Players AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) in 2024
Figure 59. South America AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Type (2020-2031)
Figure 60. Middle East and Africa AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Application (2020-2031)
Figure 61. GCC Countries AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)
Figure 62. Israel AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)
Figure 63. Egypt AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)
Figure 64. South Africa AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)
Figure 65. AI Medical Imaging Software for Lung Diseases Industry Chain Mapping
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232